CA2153733A1 - Compositions immunogenes a base d'oligosaccharides - Google Patents
Compositions immunogenes a base d'oligosaccharidesInfo
- Publication number
- CA2153733A1 CA2153733A1 CA002153733A CA2153733A CA2153733A1 CA 2153733 A1 CA2153733 A1 CA 2153733A1 CA 002153733 A CA002153733 A CA 002153733A CA 2153733 A CA2153733 A CA 2153733A CA 2153733 A1 CA2153733 A1 CA 2153733A1
- Authority
- CA
- Canada
- Prior art keywords
- polysaccharide
- conjugate
- carrier
- composition
- oligosaccharide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002153733A CA2153733A1 (fr) | 1995-07-12 | 1995-07-12 | Compositions immunogenes a base d'oligosaccharides |
| JP9500049A JPH11506110A (ja) | 1995-06-07 | 1996-06-06 | 免疫原性および免疫刺激性オリゴサッカライド組成物ならびにそれらの作製法および使用法 |
| CZ973278A CZ327897A3 (cs) | 1995-06-07 | 1996-06-06 | Imunogenní a imunostimulační oligosacharidové kompozice, způsoby jejich přípravy a použití |
| PCT/CA1996/000387 WO1996040225A1 (fr) | 1995-06-07 | 1996-06-06 | Compositions oligasaccharidiques immunogenes et immunostimulatrices et leurs procedes de production et d'utilisations |
| KR1019970707283A KR19990007777A (ko) | 1995-06-07 | 1996-06-06 | 면역성 및 면역자극성 올리고당 조성물 및 이를 제조하고 이용하는 방법 |
| IL12158596A IL121585A0 (en) | 1995-06-07 | 1996-06-06 | Immunogenic and immunostimulatory oligosaccharide compositions and methods of preparing and using them |
| EP96917311A EP0831894A1 (fr) | 1995-06-07 | 1996-06-06 | Compositions oligasaccharidiques immunogenes et immunostimulatrices et leurs procedes de production et d'utilisations |
| AU59944/96A AU725279B2 (en) | 1995-06-07 | 1996-06-06 | Immunogenic and immunostimulatory oligosaccharide compositions and methods of making and using them |
| NZ337730A NZ337730A (en) | 1995-06-07 | 1996-06-06 | use of an oligosaccharide hapten- carrier conjugate for immunizing against a bacterial or viral pathogen by administering |
| NZ309713A NZ309713A (en) | 1995-06-07 | 1996-06-06 | Oligosaccharides of S pneumoniae serotype 8 and their use in a vaccine |
| NO974727A NO974727L (no) | 1995-06-07 | 1997-10-13 | Immunogene og immunostimulatoriske oligosakkarid sammensetninger og fremgangsmåter for fremstilling derav |
| MX9707944A MX9707944A (es) | 1995-06-07 | 1997-10-15 | Composiciones de oligosacaridos inmunigenicos e inmunoestimulatorios y metodos para fabricarlos y utilizarlos. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002153733A CA2153733A1 (fr) | 1995-07-12 | 1995-07-12 | Compositions immunogenes a base d'oligosaccharides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2153733A1 true CA2153733A1 (fr) | 1997-01-13 |
Family
ID=4156211
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002153733A Abandoned CA2153733A1 (fr) | 1995-06-07 | 1995-07-12 | Compositions immunogenes a base d'oligosaccharides |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2153733A1 (fr) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11123417B2 (en) | 2018-02-05 | 2021-09-21 | Sanofi Pasteur Inc. | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US11147864B2 (en) | 2018-02-05 | 2021-10-19 | Sanofi Pasteur Inc. | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| EP3678694A4 (fr) * | 2017-09-07 | 2021-10-20 | Merck Sharp & Dohme Corp. | Procédés de formulation de polysaccharides pneumococciques pour conjugaison à une protéine porteuse |
| US11224652B2 (en) | 2016-08-05 | 2022-01-18 | Sanofi Pasteur Inc. | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US11241489B2 (en) | 2016-08-05 | 2022-02-08 | Sanofi Pasteur Inc. | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US11400162B2 (en) | 2017-02-24 | 2022-08-02 | Merck Sharp & Dohme Llc | Processes for the formulation of pneumococcal polysaccharides for conjugation to a carrier protein |
| US11951162B2 (en) | 2018-04-18 | 2024-04-09 | Sk Bioscience Co., Ltd. | Streptococcus pneumoniae capsular polysaccharides and immunogenic conjugate thereof |
-
1995
- 1995-07-12 CA CA002153733A patent/CA2153733A1/fr not_active Abandoned
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11224652B2 (en) | 2016-08-05 | 2022-01-18 | Sanofi Pasteur Inc. | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US11241489B2 (en) | 2016-08-05 | 2022-02-08 | Sanofi Pasteur Inc. | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US11400162B2 (en) | 2017-02-24 | 2022-08-02 | Merck Sharp & Dohme Llc | Processes for the formulation of pneumococcal polysaccharides for conjugation to a carrier protein |
| EP3678694A4 (fr) * | 2017-09-07 | 2021-10-20 | Merck Sharp & Dohme Corp. | Procédés de formulation de polysaccharides pneumococciques pour conjugaison à une protéine porteuse |
| US12161721B2 (en) | 2017-09-07 | 2024-12-10 | Merck Sharp & Dohme Llc | Processes for the formulation of pneumococcal polysaccharides for conjugation to a carrier protein |
| US11123417B2 (en) | 2018-02-05 | 2021-09-21 | Sanofi Pasteur Inc. | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US11147864B2 (en) | 2018-02-05 | 2021-10-19 | Sanofi Pasteur Inc. | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US11911452B2 (en) | 2018-02-05 | 2024-02-27 | Sanofi Pasteur Inc. | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US12605435B2 (en) | 2018-02-05 | 2026-04-21 | Sanofi Pasteur Inc. | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US11951162B2 (en) | 2018-04-18 | 2024-04-09 | Sk Bioscience Co., Ltd. | Streptococcus pneumoniae capsular polysaccharides and immunogenic conjugate thereof |
| US12440548B2 (en) | 2018-04-18 | 2025-10-14 | Sk Bioscience Co., Ltd. | Streptococcus pneumoniae capsular polysaccharides and immunogenic conjugate thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6132723A (en) | Immunogenic oligosaccharide compositions | |
| AU725279B2 (en) | Immunogenic and immunostimulatory oligosaccharide compositions and methods of making and using them | |
| US5916571A (en) | Immunostimulating activity of streptococcus pneumoniae serotype 8 oligosaccharides | |
| KR102225282B1 (ko) | 접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도 | |
| TWI748810B (zh) | 包含結合之莢膜醣抗原的免疫原組合物及其用途 | |
| EP2170391B1 (fr) | Polysaccharides modifiés pour vaccins conjugués | |
| WO2019175145A1 (fr) | Vaccins contre des infections des voies urinaires | |
| HU228384B1 (en) | Vaccine compositions | |
| CN105307684A (zh) | 非直链糖缀合物 | |
| CA2153733A1 (fr) | Compositions immunogenes a base d'oligosaccharides | |
| US9144604B2 (en) | Vaccine for Shigella | |
| Lee | Bacterial capsular polysaccharides: immunogenicity and vaccines | |
| US5952454A (en) | Linking compounds useful for coupling carbohydrates to amine-containing carriers | |
| CA2153730A1 (fr) | Activite immunostimulatrice d'un oligosaccharide de serotype 8 de streptococcus pneumoniae | |
| US12453764B2 (en) | Haemophilus influenzae saccharide-carrier conjugate compositions and uses thereof | |
| Malcolm et al. | Surface layers from Bacillus alvei as a carrier for a Streptococcus pneumoniae conjugate vaccine | |
| BERGQUIST et al. | Antibody responses in serum and lung to intranasal immunization with Haemophilus influenzae type b polysaccharide conjugated to cholera toxin B subunit and tetanus toxoid | |
| CN101130071B (zh) | 疫苗 | |
| JP2016525507A (ja) | 緑膿菌ワクチンのための合成オリゴ糖 | |
| US20110236414A1 (en) | Bacterial Polysaccharide-Polypeptide Conjugate Compositions | |
| ES2942133T3 (es) | Purificación de polisacárido capsular estreptocócico | |
| WO2025021712A1 (fr) | Composition immunogène | |
| Messner et al. | Zina Mosleh* and Frank M. Unger | |
| HK1142261A (en) | Modified polysaccharides for conjugate vaccines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |
Effective date: 20060228 |